Tenax Therapeutics, Inc. · NASDAQ:TENX
Vivo Opportunity Fund Holdings, L.P. reported a 9.00% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Vivo Opportunity Fund Holdings, L.P. reported a 9.00% stake in Tenax Therapeutics, Inc., 3,458,327 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.00%
- Shares
- 3,458,327
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 9.00% | 3,458,327 |
| Vivo Opportunity, LLC | 9.00% | 3,458,327 |
Source
Related
- Tenax Therapeutics, Inc.
- Vivo Opportunity, LLC
- Tenax Therapeutics, Inc. shareholders
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026